| Application no. and date | 17754688.4 (espacenet) (Federated) (European Patent Register), 20170814 | | Patent/reg. no. and date | DK/EP 3504239, 20240529 | | Publication date | 20190703 | | Priority no. and date | EP 16185704, 20160825 | | EP pub. no. and date |
EP 3504239 20190703 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | | | Inventor | HOVES, Sabine, Schlossbergstr. 6
82392 Habach, DE,
RIES, Carola, St.-Klara-Str. 9
82377 Penzberg, DE,
RUETTINGER, Dominik, Seestr. 13
82418 Seehausen, DE,
SADE, Hadassah Sumum, Oberanger 4
82377 Penzberg, DE,
OOI, Chia-Huey,
4058 Basel, DE,
ROMAGNOLI, Solange,
4052 Basel, CH | | Representative | | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | INTERMITTENT DOSING OF AN ANTI-CSF-1R ANTIBODY IN COMBINATION WITH MACROPHAGE ACTIVATING AGENT | | Int. application no. | EP2017070570 | | Int. publication no. | WO2018036852 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
